Camilla O. Hoff
0000-0002-4618-8438
Publication & Citation Trends
Publications
0 total
Exploring TROP2 expression in oropharyngeal squamous cell carcinoma: Association with prognosis and tumor immune microenvironment composition.
Cited by 0
Semantic Scholar
Clinical Outcomes With Notch Inhibitors in Notch‐Activated Recurrent/Metastatic Adenoid Cystic Carcinoma OA
Cited by 6
Semantic Scholar
Survival outcomes of pulmonary metastasis‐directed local therapy in adenoid cystic carcinoma
Cited by 2
Semantic Scholar
TROP2 Expression in Salivary Gland Adenoid Cystic Carcinoma (ACC) According to Histologic Subtype: Therapeutic Implications
Cited by 0
Semantic Scholar
Comparing RECIST, Choi, modified Choi (mChoi) and viable tumor volume (VTV) in predicting clinical benefit of vascular endothelial growth factor receptor inhibitors (VEGFRi) in patients (pts) with recurrent/metastatic (R/M) adenoid cystic carcinoma (ACC).
Cited by 0
Semantic Scholar
The immunological milieu of oropharyngeal squamous cell carcinoma (OPC) according to HPV and smoking status and its influence on prognosis.
Cited by 0
Semantic Scholar
Prognostic value of tumor volume doubling time in lung-metastatic adenoid cystic carcinoma.
Cited by 3
Semantic Scholar
Axitinib plus avelumab for recurrent/metastatic adenoid cystic carcinoma (R/M ACC): Biomarker analysis of the phase II trial.
Cited by 0
Semantic Scholar
Research Topics
Salivary Gland Tumors Diagnosis and Treatment
(17)
Head and Neck Surgical Oncology
(13)
Ear and Head Tumors
(13)
Sinusitis and nasal conditions
(6)
Pancreatic and Hepatic Oncology Research
(5)
Affiliations
The University of Texas MD Anderson Cancer Center
University of Miami
Universidade de São Paulo
Aarhus University Hospital
Jackson Memorial Hospital